CCA
ABBV icon

Clearwater Capital Advisors’s AbbVie ABBV Stock Holding History

Clearwater Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$376K Buy
1,731
+104
+6% +$23.1K 0.03% 131
2025
Q4 		$372K Sell
1,627
-51
-3% -$11.6K 0.03% 134
2025
Q3 		$389K Buy
1,678
+30
+2% +$6.11K 0.03% 126
2025
Q2 		$306K Hold
1,648
– – 0.03% 135
2025
Q1 		$345K Sell
1,648
-90
-5% -$17.5K 0.03% 133
2024
Q4 		$309K Sell
1,738
-57
-3% -$10.5K 0.03% 139
2024
Q3 		$354K Buy
1,795
+41
+2% +$7.65K 0.03% 129
2024
Q2 		$301K Buy
1,754
+16
+0.9% +$2.65K 0.03% 127
2024
Q1 		$316K Sell
1,738
-209
-11% -$36K 0.03% 127
2023
Q4 		$302K Buy
1,947
+88
+5% +$12.8K 0.03% 123
2023
Q3 		$277K Buy
1,859
+69
+4% +$10.1K 0.03% 115
2023
Q2 		$241K Buy
1,790
+41
+2% +$6.01K 0.03% 130
2023
Q1 		$279K Sell
1,749
-39
-2% -$5.96K 0.03% 119
2022
Q4 		$289K Hold
1,788
– – 0.04% 124
2022
Q3 		$240K Hold
1,788
– – 0.03% 137
2022
Q2 		$274K Buy
1,788
+39
+2% +$5.96K 0.04% 121
2022
Q1 		$284K Buy
+1,749
New +$254K 0.03% 137
2019
Q1 		– Sell
-2,607
Closed -$240K – 191
2018
Q4 		$240K Buy
2,607
+380
+17% +$33.4K 0.05% 181
2018
Q3 		$211K Buy
+2,227
New +$211K 0.04% 183
2018
Q2 		– Sell
-2,055
Closed -$195K – 182
2018
Q1 		$195K Buy
+2,055
New +$226K 0.04% 182
2017
Q4 		– Sell
-2,895
Closed -$263K – 176
2017
Q3 		$263K Buy
+2,895
New +$220K 0.06% 150

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clearwater Capital Advisors's ABBV Position: Q1 2026 in Review

Clearwater Capital Advisors increased its AbbVie (ABBV) stake by 6.4% in Q1 2026, buying an estimated $23.1K and bringing the position to 1,731 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #131.

Clearwater Capital Advisors first reported a position in ABBV in Q3 2017 and has held it in 21 quarters since. The position peaked at $389K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Clearwater Capital Advisors held 1,731 shares of AbbVie worth $376K as of Q1 2026.
  • Clearwater Capital Advisors bought 104 AbbVie shares in Q1 2026, an estimated $23.1K.
  • AbbVie made up 0.03% of Clearwater Capital Advisors's portfolio in Q1 2026, its #131 holding.
  • Clearwater Capital Advisors first reported a position in AbbVie in Q3 2017 and has held it in 21 quarters since.
  • Clearwater Capital Advisors's AbbVie position peaked at $389K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Clearwater Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.